Literature DB >> 26858455

Pathophysiological implication of CaV3.1 T-type Ca2+ channels in trigeminal neuropathic pain.

Soonwook Choi1, Eunah Yu1, Eunjin Hwang2, Rodolfo R Llinás3.   

Abstract

A crucial pathophysiological issue concerning central neuropathic pain is the modification of sensory processing by abnormally increased low-frequency brain rhythms. Here we explore the molecular mechanisms responsible for such abnormal rhythmicity and its relation to neuropathic pain syndrome. Toward this aim, we investigated the behavioral and electrophysiological consequences of trigeminal neuropathic pain following infraorbital nerve ligations in CaV3.1 T-type Ca(2+) channel knockout and wild-type mice. CaV3.1 knockout mice had decreased mechanical hypersensitivity and reduced low-frequency rhythms in the primary somatosensory cortex and related thalamic nuclei than wild-type mice. Lateral inhibition of gamma rhythm in primary somatosensory cortex layer 4, reflecting intact sensory contrast, was present in knockout mice but severely impaired in wild-type mice. Moreover, cross-frequency coupling between low-frequency and gamma rhythms, which may serve in sensory processing, was pronounced in wild-type mice but not in CaV3.1 knockout mice. Our results suggest that the presence of CaV3.1 channels is a key element in the pathophysiology of trigeminal neuropathic pain.

Entities:  

Keywords:  central pain; cross-frequency coupling; lateral inhibition; thalamocortical dysrhythmia

Mesh:

Substances:

Year:  2016        PMID: 26858455      PMCID: PMC4776481          DOI: 10.1073/pnas.1600418113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Thalamocortical dysrhythmia and chronic pain.

Authors:  Edward G Jones
Journal:  Pain       Date:  2010-04-14       Impact factor: 6.961

2.  Development of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthood.

Authors:  Raymond Y Cho; Christopher P Walker; Nicola R Polizzotto; Thomas A Wozny; Catherine Fissell; Chi-Ming A Chen; David A Lewis
Journal:  Cereb Cortex       Date:  2013-12-10       Impact factor: 5.357

Review 3.  T-type voltage-gated calcium channels as targets for the development of novel pain therapies.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function.

Authors:  R R Llinás
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

5.  Abnormal thalamocortical activity in patients with Complex Regional Pain Syndrome (CRPS) type I.

Authors:  K D Walton; M Dubois; R R Llinás
Journal:  Pain       Date:  2010-03-24       Impact factor: 6.961

6.  Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy.

Authors:  G Guilbaud; J M Benoist; F Jazat; M Gautron
Journal:  J Neurophysiol       Date:  1990-11       Impact factor: 2.714

7.  Alterations in burst firing of thalamic VPL neurons and reversal by Na(v)1.3 antisense after spinal cord injury.

Authors:  Bryan C Hains; Carl Y Saab; Stephen G Waxman
Journal:  J Neurophysiol       Date:  2006-02-15       Impact factor: 2.714

8.  Attenuated neuropathic pain in Cav3.1 null mice.

Authors:  Heung Sik Na; Soonwook Choi; Junesun Kim; Joonoh Park; Hee-Sup Shin
Journal:  Mol Cells       Date:  2008-03-28       Impact factor: 5.034

9.  Differential brain activity in subjects with painful trigeminal neuropathy and painful temporomandibular disorder.

Authors:  Andrew M Youssef; Sylvia M Gustin; Paul G Nash; Jenna M Reeves; Esben T Petersen; Chris C Peck; Greg M Murray; Luke A Henderson
Journal:  Pain       Date:  2013-11-21       Impact factor: 6.961

10.  Thalamic control of visceral nociception mediated by T-type Ca2+ channels.

Authors:  Daesoo Kim; Donghyun Park; Soonwook Choi; Sukchan Lee; Minjeong Sun; Chanki Kim; Hee-Sup Shin
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

View more
  24 in total

Review 1.  Recent advances in the development of T-type calcium channel blockers for pain intervention.

Authors:  Terrance P Snutch; Gerald W Zamponi
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

2.  Recent advances in targeting ion channels to treat chronic pain.

Authors:  Edward B Stevens; Gary J Stephens
Journal:  Br J Pharmacol       Date:  2018-06       Impact factor: 8.739

3.  Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels.

Authors:  Jeffrey R McArthur; Rocio K Finol-Urdaneta; David J Adams
Journal:  Br J Pharmacol       Date:  2019-05-16       Impact factor: 8.739

Review 4.  Towards a Mechanistic-Driven Precision Medicine Approach for Tinnitus.

Authors:  Thanos Tzounopoulos; Carey Balaban; Lori Zitelli; Catherine Palmer
Journal:  J Assoc Res Otolaryngol       Date:  2019-03-01

5.  From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei.

Authors:  Tânia C Gonçalves; Evelyne Benoit; Michael Kurz; Laetitia Lucarain; Sophie Fouconnier; Stéphanie Combemale; Lucie Jaquillard; Brigitte Schombert; Jean-Marie Chambard; Rachid Boukaiba; Gerhard Hessler; Andrees Bohme; Laurent Bialy; Stéphane Hourcade; Rémy Béroud; Michel De Waard; Denis Servent; Michel Partiseti
Journal:  Br J Pharmacol       Date:  2019-04-09       Impact factor: 8.739

6.  CaV3.2 calcium channels: new players in facial pain.

Authors:  Kimberly Gomez; Rajesh Khanna
Journal:  Pain       Date:  2022-04-15       Impact factor: 7.926

7.  Contribution of T-Type Calcium Channels to Spinal Cord Injury-Induced Hyperexcitability of Nociceptors.

Authors:  Justas Lauzadis; Huilin Liu; Yong Lu; Mario J Rebecchi; Martin Kaczocha; Michelino Puopolo
Journal:  J Neurosci       Date:  2020-08-24       Impact factor: 6.167

Review 8.  Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways.

Authors:  Lucia Hoppanova; Lubica Lacinova
Journal:  Pflugers Arch       Date:  2022-01-18       Impact factor: 3.657

9.  An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy.

Authors:  Suguru Koyama; Brian W LeBlanc; Kelsey A Smith; Catherine Roach; Joshua Levitt; Muhammad M Edhi; Mai Michishita; Takayuki Komatsu; Okishi Mashita; Aki Tanikawa; Satoru Yoshikawa; Carl Y Saab
Journal:  Sci Rep       Date:  2018-11-06       Impact factor: 4.379

10.  Amplified parabrachial nucleus activity in a rat model of trigeminal neuropathic pain.

Authors:  Olivia Uddin; Paige Studlack; Titilola Akintola; Charles Raver; Alberto Castro; Radi Masri; Asaf Keller
Journal:  Neurobiol Pain       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.